News Image

Updated: Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences

Provided By GlobeNewswire

Last update: May 14, 2025

SALT LAKE CITY, May 14, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that management plans to participate in the following investor healthcare conferences:

Read more at globenewswire.com

MYRIAD GENETICS INC

NASDAQ:MYGN (6/12/2025, 2:31:19 PM)

5.12

-0.06 (-1.16%)



Find more stocks in the Stock Screener

Follow ChartMill for more